BioPlx Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $187K

BioPlx General Information

Description

Operator of a microbiome research analysis company intended to develop non-antibiotic treatments for infectious diseases. The company specializes in the research and development of targeted microbiological agents that facilitate the creation of interventional formulations, providing medical practitioners with clinically effective microbiome agents to prevent recurring staph infections.

Contact Information

Website
www.bioplx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1800 30th Street
  • Suite 213
  • Boulder, CO 80301
  • United States
+1 (303)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1800 30th Street
  • Suite 213
  • Boulder, CO 80301
  • United States
+1 (303)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioPlx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 27-Apr-2020 $187K Completed Generating Revenue
2. Seed Round 24-Feb-2020 Completed Generating Revenue
1. Seed Round 16-Aug-2019 $1.64M $1.64M Completed Generating Revenue
To view BioPlx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioPlx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a microbiome research analysis company intended to develop non-antibiotic treatments for infectious diseases
Drug Discovery
Boulder, CO

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioPlx Competitors (1)

One of BioPlx’s competitors is Second Genome, a Formerly VC-backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Genome Formerly VC-backed Brisbane, CA
You’re viewing 1 of 1 competitors. Get the full list »

BioPlx Patents

BioPlx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4158010-A1 Methods for stable genomic integration in recombinant microorganisms Pending 02-Jun-2020
CA-3181274-A1 Methods for stable genomic integration in recombinant microorganisms Pending 02-Jun-2020
EP-4158010-A4 Methods for stable genomic integration in recombinant microorganisms Pending 02-Jun-2020
CA-3146363-A1 Live biotherapeutic compositions and methods Pending 08-Jul-2019
AU-2020309551-A1 Live biotherapeutic compositions and methods Inactive 08-Jul-2019 A61K35/74
To view BioPlx’s complete patent history, request access »

BioPlx FAQs

  • When was BioPlx founded?

    BioPlx was founded in 2015.

  • Where is BioPlx headquartered?

    BioPlx is headquartered in Boulder, CO.

  • What industry is BioPlx in?

    BioPlx’s primary industry is Drug Discovery.

  • Is BioPlx a private or public company?

    BioPlx is a Private company.

  • What is BioPlx’s current revenue?

    The current revenue for BioPlx is .

  • How much funding has BioPlx raised over time?

    BioPlx has raised $2.72M.

  • Who are BioPlx’s competitors?

    Second Genome is a competitor of BioPlx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »